Differences of Serum Progesterone-Induced Blocking Factor (PIBF) Levels in Pregnant Women with Abortus Imminent and Normal Pregnancy (Study on Pregnancy I Trimester)

Syarief Thaufik Hidayat; Muhammad Reza  Hidayat

doi:10.36418/syntax-literate.v10i7.60748

Syarief Thaufik Hidayat Universitas Diponegoro, Indonesia
Muhammad Reza Hidayat Universitas Diponegoro, Indonesia

DOI: https://doi.org/10.36418/syntax-literate.v10i7.60748

Keywords: PIBF, abortion imminent, normal pregnancy, gestational age

Abstract

To determine the difference in serum Progesterone-Induced Blocking Factor (PIBF) levels in first-trimester pregnant women between abortion imminent and normal pregnancy. An analytical observational study with a cross-sectional method involving 54 research subjects consisting of 27 pregnant women with imminent abortion and 27 pregnant women with normal pregnancies. The dependent variable in this study was serum PIBF levels. In the imminent abortion group, PIBF levels had a mean of 59.43 ng/mL with a standard deviation of 9.05 ng/mL, a median value of 58.24 ng/mL with the smallest value of 47.95 ng/mL, and the largest value of 75.82 ng/mL. There was a correlation between gestational age (p<0.001) and PIBF levels with a strong negative correlation level (r= -0.775). In the normal pregnancy group, PIBF levels had a mean of 111.53 ng/mL with a standard deviation of 24.71 ng/mL, a median value of 108.51 ng/mL with the smallest value of 79.88 ng/mL, and the largest value of 191.14 ng/mL. There was a correlation between gestational age (p=0.049) and PIBF levels with a moderately positive correlation level (r=0.361). There was a significant difference in PIBF levels (p<0.001) between the abortion imminent group and the normal pregnancy group. Subjects with PIBF levels <77.85 ng/mL were at risk for imminent abortion than subjects with PIBF levels > 77.85 ng/mL. PIBF levels were significantly lower in the abortion imminent group than in the normal pregnancy group. In the abortion imminent group, an increase in gestational age was moderately correlated with a decrease in PIBF levels.

Downloads

Download data is not yet available.

References

1. Breeze C. Early pregnancy bleeding. Aust J Gen Pract. 2016;45(5):283�6.
2. Prawirohardjo S. Nyeri Perut pada Kehamilan Muda. In: Ilmu Kebidanan. Bina Pustaka; 2016. p. 659�66.
3. Leveno KJ, Spong CY, Dashe JS, Casey BM, Hoffman BL, Cunningham FG, et al. Abortion. In: Williams Obstetric. McGraw-Hill Education; 2018. p. 138�47.
4. Pranata S, Sadewo FS. Kejadian keguguran, kehamilan tidak direncanakan dan pengguguran di indonesia. Buletin Penelitian Sistem Kesehatan. 2012;15(4):180�92.
5. Defrin D, Ardinal A, Erkadius E. Perbedaan Rerata Kadar Progesterone-Induced Blocking Factor (PIBF) Serum Penderita Abortus Iminens dengan Kehamilan Normal. Jurnal Kesehatan Andalas. 2017;6(2):463.
6. Young BK. A multidisciplinary approach to pregnancy loss: The pregnancy loss prevention center. J Perinat Med. 2019;47(1):41�4.
7. Defrin D, Ardinal A, Erkadius E. Perbedaan Rerata Kadar Progesterone-Induced Blocking Factor (PIBF) Serum Penderita Abortus Iminens dengan Kehamilan Normal. Jurnal Kesehatan Andalas. 2017;6(2):463
8. Betris M. Analisis Faktor Risiko Kejadian Abortus Pada Ibu Hamil di Kota Pariaman. Jurnal Kesehatan Andalas. 2020
9. Lim MK, Ku CW, Tan TC, Lee YHJ, Allen JC, Tan NS. Characterization of serum progesterone and progesterone-induced blocking factor (PIBF) levels across trimesters in healthy pregnant women. Sci Rep. 2020;10(1):1�9
10. Widya AC, Loho MF, Wantania JJE. The Role of Progesterone Induced Blocking Factor in Threatened Abortion. Indonesian Journal of Obstetrics and Gynecology. 2017 Dec 8;193.
11. Hudi? I, Fatu�i? Z. Progesterone � induced blocking factor (PIBF) and Th1/Th2 cytokine in women with threatened spontaneous abortion. J Perinat Med. 2009 Jan 1;37(4).
12. Kavalier F. Investigation of recurrent miscarriages. BMJ. 2005 Jul 16;331(7509):121�2.
13. Kalinka J, Szekeres-Bartho J. The Impact of Dydrogesterone Supplementation on Hormonal Profile and Progesterone-induced Blocking Factor Concentrations in Women with Threatened Abortion. American Journal of Reproductive Immunology. 2005 Apr;53(4):166�71.
14. Raghupathy R. Cytokine imbalance in pregnancy complications and its modulation. Frontiers in Bioscience. 2008;13(13):985.
15. Abadi A, Baziad A, Hestiantoro A. The benefits of progesterone therapy in imminent abortion. Medical Journal of Indonesia. 2005 Nov 1;258.
16. Daya S. Luteal support: Progestogens for pregnancy protection. Maturitas. 2009 Dec;65:S29�34.
17. Szekeres-Bartho J. Role of progesterone and progestin therapy in threatened abortion and preterm labor. Frontiers in Bioscience. 2008;13(13):1981.
18. Nardo LG, Sallam HN. Progesterone supplementation to prevent recurrent miscarriage and reduce implantation failure in assisted reproduction cycles. Reprod Biomed Online. 2006 Jan;13(1):47�57.
19. Speroff L, Fritz MA. Clinical Gynecologic Endocrinology and Infertility. Seventh. Philadelphia: Williams & Wilkins; 2005.
20. Shah D, Nagarajan N. Luteal insufficiency in the first trimester. Indian J Endocrinol Metab. 2013;17(1):44.
21. Polga?r B, Nagy E, Miko? E, Varga P, Szekeres-Bartho? J. Urinary Progesterone-Induced Blocking Factor Concentration Is Related to Pregnancy Outcome1. Biol Reprod. 2004 Nov 1;71(5):1699�705.
22. Kwak-Kim JYH. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and infertile women with multiple implantation failures after IVF. Human Reproduction. 2003 Apr 1;18(4):767�73.
23. Andersen AMN. Maternal age and fetal loss: population based register linkage study. BMJ. 2000 Jun 24;320(7251):1708�12.
24. Stocco C, Telleria C, Gibori G. The Molecular Control of Corpus Luteum Formation, Function, and Regression. Endocr Rev. 2007 Feb 1;28(1):117�49.
25. Duncan WC. The inadequate corpus luteum. Reproduction and Fertility. 2021 Feb 26;2(1): C1�7.
26. Mesiano S. Endocrinology of Human Pregnancy and Fetal-Placental Neuroendocrine Development. In: Yen and Jaffe�s Reproductive Endocrinology. Elsevier; 2019. p. 256-284.e9.
27. Blois SM, Joachim R, Kandil J, Margni R, Tometten M, Klapp BF, et al. Depletion of CD8 + Cells Abolishes the Pregnancy Protective Effect of Progesterone Substitution with Dydrogesterone in Mice by Altering the Th1/Th2 Cytokine Profile. The Journal of Immunology. 2004 May 15;172(10):5893�9.
28. Dettmer AM, Rosenberg KL, Suomi SJ, Meyer JS, Novak MA. Associations between Parity, Hair Hormone Profiles during Pregnancy and Lactation, and Infant Development in Rhesus Monkeys (Macaca mulatta). PLoS One. 2015 Jul 14;10(7):e0131692.
29. Szekeres-Bartho J, Polgar B. PIBF: The Double Edged Sword. Pregnancy and Tumor. American Journal of Reproductive Immunology. 2010 Mar;
30. Szekeres-Bartho J. The Role of Progesterone in Feto-Maternal Immunological Cross Talk. Medical Principles and Practice. 2018;27(4):301�7.